Cingulate Inc —— 季度财务数据 (NASDAQ:CING) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -4.08 M-4.61 M-4.8 M-4.24 M-3.6 M -17.25 M 投资活动产生的现金 -198.46 K0-5 9250-156.21 K -162.14 K 融资活动产生的现金 6.45 M1.92 M4.18 M1.46 M8.59 M 16.15 M 自由现金流 -4.28 M-4.61 M-4.8 M-4.24 M-3.75 M -17.41 M

新闻

Cingulate将场外发行上限提高至3190万美元

Cingulate increases at-the-market offering limit to $31.9 million

Cingulate重新任命Shane Schaffer为首席执行官，更新雇佣条款

Cingulate reinstates Shane Schaffer as CEO, updates employment terms

Cingulate appoints new CCO, secures $6 million financing

Cingulate’s ADHD drug meets primary endpoints in phase 3 trial

FDA接受Cingulate的ADHD药物申请，设定2026年5月目标日期

FDA accepts Cingulate’s ADHD drug application, sets May 2026 target date

Cingulate与Bend Bio Sciences达成ADHD药物生产协议

Cingulate secures manufacturing deal with Bend Bio Sciences for ADHD drug

Cingulate issues shares to lender in series of unregistered transactions

Cingulate appoints John A. Roberts as executive chairman, CEO placed on leave